A detailed history of Mackenzie Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 91,490 shares of EW stock, worth $5.99 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
91,490
Previous 95,504 4.2%
Holding current value
$5.99 Million
Previous $9.13 Million 7.41%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $338,380 - $378,560
-4,014 Reduced 4.2%
91,490 $8.45 Million
Q1 2024

May 10, 2024

BUY
$72.54 - $95.56 $248,231 - $327,006
3,422 Added 3.72%
95,504 $9.13 Million
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $4.14 Million - $5.21 Million
-67,034 Reduced 42.13%
92,082 $7.02 Million
Q3 2023

Oct 25, 2023

BUY
$69.28 - $93.38 $1.33 Million - $1.79 Million
19,208 Added 13.73%
159,116 $11 Million
Q2 2023

Aug 03, 2023

SELL
$81.41 - $94.33 $40.7 Million - $47.2 Million
-500,463 Reduced 78.15%
139,908 $13.2 Million
Q1 2023

Apr 24, 2023

BUY
$74.26 - $84.51 $282,410 - $321,391
3,803 Added 0.6%
640,371 $53 Million
Q4 2022

Feb 14, 2023

SELL
$68.3 - $87.44 $5.25 Million - $6.72 Million
-76,905 Reduced 10.78%
636,568 $47.5 Million
Q3 2022

Oct 07, 2022

BUY
$82.37 - $107.29 $2.01 Million - $2.62 Million
24,438 Added 3.55%
713,473 $59 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $2.89 Million - $4.29 Million
33,468 Added 5.11%
689,035 $65.5 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $2.02 Million - $2.54 Million
19,798 Added 3.11%
655,567 $77.2 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $13.4 Million - $16.4 Million
125,610 Added 24.62%
635,769 $82.4 Million
Q3 2021

Nov 08, 2021

BUY
$102.91 - $122.75 $1.43 Million - $1.7 Million
13,874 Added 2.8%
510,159 $57.8 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $18.7 Million - $23.4 Million
223,316 Added 81.81%
496,285 $51.4 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $16.5 Million - $19 Million
209,696 Added 331.41%
272,969 $22.8 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $500,682 - $637,150
6,984 Added 12.41%
63,273 $5.77 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $1.17 Million - $1.52 Million
-17,406 Reduced 23.62%
56,289 $4.49 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $2.02 Million - $2.71 Million
35,183 Added 91.36%
73,695 $5.09 Million
Q1 2020

May 14, 2020

BUY
$52.41 - $81.0 $1.37 Million - $2.12 Million
26,211 Added 213.08%
38,512 $2.42 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $720,728 - $825,168
10,052 Added 446.95%
12,301 $2.87 Million
Q3 2019

Nov 14, 2019

BUY
$61.55 - $75.43 $38,284 - $46,917
622 Added 38.23%
2,249 $495,000
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $26,476 - $30,594
-475 Reduced 22.6%
1,627 $301,000
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $192,565 - $257,545
-4,021 Reduced 65.67%
2,102 $402,000
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $176,914 - $217,055
-3,812 Reduced 38.37%
6,123 $938,000
Q3 2018

Nov 15, 2018

BUY
$45.7 - $58.03 $65,579 - $83,273
1,435 Added 16.88%
9,935 $1.73 Million
Q2 2018

Aug 13, 2018

BUY
$42.45 - $51.3 $32,134 - $38,834
757 Added 9.78%
8,500 $1.24 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $76,499 - $97,604
2,057 Added 36.18%
7,743 $1.08 Million
Q4 2017

Feb 13, 2018

BUY
$33.79 - $39.39 $44,906 - $52,349
1,329 Added 30.5%
5,686 $641,000
Q3 2017

Nov 13, 2017

BUY
$36.29 - $38.83 $15,459 - $16,541
426 Added 10.84%
4,357 $476,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,931
3,931 $465,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.